Recent advances in the prevention of anthracycline cardiotoxicity in childhood.
about
Metformin protects cardiomyocyte from doxorubicin induced cytotoxicity through an AMP-activated protein kinase dependent signaling pathway: an in vitro studyTranscriptome profiling of peripheral blood cells identifies potential biomarkers for doxorubicin cardiotoxicity in a rat modelCardiomyocyte death in doxorubicin-induced cardiotoxicityAngiotensin-converting enzyme 2 overexpression protects against doxorubicin-induced cardiomyopathy by multiple mechanisms in rats.Effects of doxorubicin on cardiac muscle subsarcolemmal and intermyofibrillar mitochondria.Screening a panel of drugs with diverse mechanisms of action yields potential therapeutic agents against neuroblastoma.Acute doxorubicin cardiotoxicity is associated with miR-146a-induced inhibition of the neuregulin-ErbB pathway.Inauhzin sensitizes p53-dependent cytotoxicity and tumor suppression of chemotherapeutic agents.Anthracycline-induced cardiotoxicity and the cardiac-sparing effect of liposomal formulation.Comparison of doxorubicin cardiotoxicity in pediatric sarcoma patients when given with dexrazoxane versus as continuous infusion.The Protective Role of Phenolic Compounds Against Doxorubicin-induced Cardiotoxicity: A Comprehensive Review.Pathways of cardiac toxicity: comparison between chemotherapeutic drugs doxorubicin and mitoxantrone.The role of nitric oxide in Doxorubicin-induced cardiotoxicity: experimental study.Tissue and flow myocardial performance index measurements taken during dobutamine stress echocardiography for early diagnosis of late anthracycline cardiotoxicity.Differential toxicity of anthracyclines on cultured endothelial cells.Late anthracycline cardiotoxicity protection by dexrazoxane (ICRF-187) in pediatric patients: echocardiographic follow-up.Long-term serial echocardiographic examination of late anthracycline cardiotoxicity and its prevention by dexrazoxane in paediatric patients.Preventive cardioprotection of erythropoietin against doxorubicin-induced cardiomyopathy.An initial health economic evaluation of pharmacogenomic testing in patients treated for childhood cancer with anthracyclines.
P2860
Q28541996-2CDBE3B7-DC74-47A0-975E-0FE894D97EFEQ33404672-A1781F65-609F-47AF-A02E-53C146D65222Q33604134-A9BAB67E-2A50-4C40-BEAB-BE51119B5446Q33648557-83C44872-CE96-4B2A-A8D6-906A0ADF4F4AQ33649513-AE0B3651-662B-40E0-8D8F-1272764CFE99Q33691241-C4FDC394-7526-45C4-8E53-9877FD97A5DBQ34062716-0ECD16D7-7913-4855-AECF-D481238B748EQ36801098-A7D60E24-448C-4968-9211-72E916EDC05BQ37059896-9BA89F4E-9D26-4322-8719-B4309BE9E5F8Q37783289-C82731B9-B307-46F6-8AEA-80FD8FED0607Q38875916-41B7E2D8-D76C-4334-B5C6-7F20107CF9A9Q38876257-146E1FEB-4217-449B-B8E8-C1C84FF6FCEDQ38914599-C706CFF8-AD78-44D4-9369-2D42753797C7Q43236070-A222A38A-36BF-4C34-9A9F-4AFBD51EF943Q46374470-DB595461-19F2-468E-AAA3-D8DDC1627409Q46611256-30B0F4E8-6F9C-4297-AE63-F3F325C849CEQ46619189-1C43A00D-1DC9-459D-8797-D0C7A5750B59Q46960036-F484464C-0FFE-4C4D-8AE2-B41DFB088BC3Q48357803-F042B4C7-BAF4-4975-B557-09423C650860
P2860
Recent advances in the prevention of anthracycline cardiotoxicity in childhood.
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Recent advances in the prevention of anthracycline cardiotoxicity in childhood.
@ast
Recent advances in the prevention of anthracycline cardiotoxicity in childhood.
@en
Recent advances in the prevention of anthracycline cardiotoxicity in childhood.
@nl
type
label
Recent advances in the prevention of anthracycline cardiotoxicity in childhood.
@ast
Recent advances in the prevention of anthracycline cardiotoxicity in childhood.
@en
Recent advances in the prevention of anthracycline cardiotoxicity in childhood.
@nl
prefLabel
Recent advances in the prevention of anthracycline cardiotoxicity in childhood.
@ast
Recent advances in the prevention of anthracycline cardiotoxicity in childhood.
@en
Recent advances in the prevention of anthracycline cardiotoxicity in childhood.
@nl
P2093
P356
P1476
Recent advances in the prevention of anthracycline cardiotoxicity in childhood.
@en
P2093
Coppolino P
Di Tullio MT
Tedesco MA
P304
P356
10.2174/0929867013371888
P577
2001-11-01T00:00:00Z